Navigation Links
CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
Date:8/5/2011

EMERYVILLE, Calif., Aug. 5, 2011 /PRNewswire/ -- CORRECTED -- Bionovo, Inc. (NASDAQ: BNVI) today announced second quarter highlights and financial results for the three months ended June 30, 2011.

"We have made excellent progress on our menopausal hot flash drug candidate, MF101, or Menerba™, during the past quarter, delivering on milestones and commitments," said Isaac Cohen, O.M.D., Bionovo's Chairman and Chief Executive Officer. "We have completed the tasks which were required for us to begin the phase 3 clinical trial for Menerba, and we are on track to initiate the trial in the third quarter."

Key Events and Milestones

  • The Company successfully completed non-clinical toxicology studies of Menerba in two animal species.  As expected no serious adverse events or toxicities were observed in these studies. The drug was well tolerated by the animals.
  • The Company successfully completed a 28-day tolerability trial of Menerba in women, investigating higher doses. As expected, there were no safety concerns, no reports of serious adverse events, no changes to blood pressure, heart rate or lab values and no cases of abnormal uterine findings on endometrial biopsies.  A dosing strategy has been established for the phase 3 study.
  • The Company completed the manufacture of the requisite ten batches for the phase 3 clinical trial of Menerba, and is preparing the submission of data to the FDA.
  • The Company has identified, selected, and is working with personnel at 45 initial clinical trial sites for the phase 3 clinical trial of Menerba.
  • The Company also published further information on the mechanism of action of its breast cancer drug candidate, Bezielle™, as well as further information on novel approaches for the quantification of actives in botanical drug mixtures.
  • The Company presented data from
    '/>"/>

  • SOURCE Bionovo, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
    2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
    3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
    4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
    5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
    6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
    7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
    8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
    9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
    10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
    11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... July 10, 2014   LabStyle Innovations Corp ... today announced the appointment of Professor Richard ... its Board of Directors. Prof. Stone ... experience to LabStyle as an entrepreneur, venture capitalist ... corporate governance expert. He currently serves on the ...
    (Date:1/15/2014)... Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today ... 30, 2013, compared to sales of $2,202,000 for the prior ... this quarter has also shown growth over the preceding quarter,s ... of this fiscal year. Markets that experienced sales increases over ...
    (Date:1/15/2014)... DUBLIN , Jan. 15, 2014  Research and Markets ... "Dental Consumables Market - Global Industry Analysis, Size, ... report to their offering. (Logo: ... products which are used on patients in order to ...
    Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
    ... 2010 MiMedx Group, Inc. (OTC Bulletin Board: ... of patent protected biomaterial-based products, announced today that it ... a leader in the development of tissue processing techniques ... from amnion membranes. Privately held Surgical Biologics ...
    ... Today, Pepex Biomedical, Inc. took delivery of bench ... One-Click blood glucose meter. During the last year, a ... Pepex engineers, designed and devolved bench prototypes and production ... key requirements of the new meter concept and, of ...
    Cached Medicine Technology:MiMedx Announces Agreement to Acquire Surgical Biologics 2MiMedx Announces Agreement to Acquire Surgical Biologics 3MiMedx Announces Agreement to Acquire Surgical Biologics 4MiMedx Announces Agreement to Acquire Surgical Biologics 5Prototypes of Pepex™ Trio™ One-Click™ Meter Delivered 2Prototypes of Pepex™ Trio™ One-Click™ Meter Delivered 3
    (Date:7/12/2014)... it doesn't matter what your budget is, the trendy wedding ... affordable gown can visit Discount-Dress.com (a reliable online ... items. Recently, the company has announced its new selection of ... it is also providing great discounts for these unique items. ... this promotion is July 29, 2014. , Discount-Dress.com is ...
    (Date:7/11/2014)... July 12, 2014 Recently, DressyQuinceanera.com, a ... Quinceanera Dama dresses to its online category. ... are offered at deeply discounted rates, up to 62% ... DressyQuinceanera.com are equally excellent in terms of quality and ... handmade. Similar discounts are also offered for the company’s ...
    (Date:7/11/2014)... 12, 2014 According to new ... market is expected to register a CAGR of ... Browse 71 market data tables and 76 figures ... "C4ISR Market"., http://www.marketsandmarkets.com/Market-Reports/c4isr-market-1315.html , Early buyers ... http://www.marketsandmarkets.com/requestCustomization.asp?id=1315 , The report provides market analysis ...
    (Date:7/11/2014)... (PRWEB) July 11, 2014 As ... filed against Johnson & Johnson’s Ethicon Inc. unit ... LLP notes that the Texas Attorney General’s Office ... marketing of surgical mesh products used to treat ... to a report from kens5.com, the probe began ...
    (Date:7/11/2014)... (HealthDay News) -- Reducing the number of deer in ... disease and other tick-borne infections among people, new research ... be manipulated to reduce human interactions with deer, infected ... the researchers wrote. White-tailed deer are the primary ... to people. The study included nearly all the ...
    Breaking Medicine News(10 mins):Health News:Worldwide Brides-to-be: It Is Time To Show Your Beauty By Wearing A Trendy Summer Short Wedding Dress From Discount-Dress.com 2Health News:DressyQuinceanera.com: Beautiful Quinceanera Dama Dresses At Low Prices 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 3Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 2Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 4
    ... of ... action, PRINCETON, ... provider of advanced wound care products,announced today that the most recent study ... associated with a,reduction in wound size, possibly driven in part by a ...
    ... Administrative Cost Savings for Harvard Pilgrim Over the Life of the ... ... Perot Systems,Corporation (NYSE: PER ) and Harvard Pilgrim Health Care ... 2021., Under this new 13-year, $1 billion contract, Harvard Pilgrim will,realize ...
    ... actively-used PHR in the market, OAKLAND, Calif., April ... 2 million members are actively using the personal,health record ... find,Kaiser Permanente,s personal health record an effective way to ... are finding it difficult to attract,users, Kaiser Permanente has ...
    ... MONTVALE, N.J., April 8, 2008 Protection against,vaccine-preventable ... need protection. To make clinicians aware of the ... patients, The Journal of,Family Practice has published a ... diseases: Are adults in your community adequately,protected?, ...
    ... BOSTON, April 8, 2008 The March of ... & Moving,of Canton will serve as a statewide corporate ... WalkAmerica, March for Babies is the,March of Dimes premier ... as well as those who need help to survive ...
    ... demonstration project will test effectiveness of health,management ... chronic illness in the,Medicare population, MINNEAPOLIS, ... HFIT) announced today it is working with ... Pfizer Inc., as part of a,three-year Senior ...
    Cached Medicine News:Health News:New Study Shows the Use of MEDIHONEY(TM) Wound & Burn Dressing is Associated With Reduction in Wound Size 2Health News:New Study Shows the Use of MEDIHONEY(TM) Wound & Burn Dressing is Associated With Reduction in Wound Size 3Health News:New Study Shows the Use of MEDIHONEY(TM) Wound & Burn Dressing is Associated With Reduction in Wound Size 4Health News:Perot Systems and Harvard Pilgrim Extend IT and Business Process Service Relationship 2Health News:Perot Systems and Harvard Pilgrim Extend IT and Business Process Service Relationship 3Health News:Perot Systems and Harvard Pilgrim Extend IT and Business Process Service Relationship 4Health News:Two Million People Using Kaiser Permanente's Personal Health Record 2Health News:Adults Need Protection Against Vaccine-Preventable Diseases, Too 2Health News:Humboldt Storage & Moving to Partner with March for Babies 2Health News:Humboldt Storage & Moving to Partner with March for Babies 3Health News:HealthFitness Teams with Pfizer Health Solutions to Implement CMS Senior Risk Reduction Demonstration Project 2Health News:HealthFitness Teams with Pfizer Health Solutions to Implement CMS Senior Risk Reduction Demonstration Project 3Health News:HealthFitness Teams with Pfizer Health Solutions to Implement CMS Senior Risk Reduction Demonstration Project 4
    ... includes three major components: Blood pump, Cannulae, ... Driver. This system provides partial or total ... conventional therapy, is unable to maintain adequate ... support, blood flows from the natural heart ...
    Datascope presents a unique new product for post-hemostasis puncture site management. Safeguard is the first product ever to combine a built-in inflatable bulb and a sterile dressing- providing adjus...
    ... catheter is inserted into the subclavian or ... vena cava. The Cool Line incorporates ... temperature-controlled saline flowing within a closed-loop design, ... circulation. The Cool Line combines two ...
    ... The Fortius catheter provides maximum ... to target temperature. The Fortius catheter ... design to provide the ultimate solution ... catheter is inserted percutaneously into the ...
    Medicine Products: